E3L-24179-31135 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-28
Dose 1 — Moderna
2022-07-01
Registered in v-safe
2022-07-01
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activities

Under 3 check-in
2022-07-02
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-03
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-07-05
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-09-27
Health check-in — 3 months, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-12-29
Survey response — 6 months, dose 1, under 3
MedDRA: Conjunctivitis, Hand-foot-and-mouth disease, Influenza, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: RSV, hand, foot, and mouth, pink eye, cold/flu

MedDRA releases: 2024-11 · check-in free text available
2022-12-29
Report sent to call center — 6 months, dose 1, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-12-30
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-28	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — 6 months, dose 1, under 3

2022-12-29

Symptoms: RSV, hand, foot, and mouth, pink eye, cold/flu

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Conjunctivitis	·	·	✓
SD	Hand-foot-and-mouth disease	·	·	✓
SD	Influenza	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release